Journals
2009 EN
Sylvie Leroy · V. Conseil · Bérangère Coltey
+22 more
175 Evaluation and management of fungal risk in Cystic Fibrosis: first results of a national French study S. Leroy1, V. Conseil1, B. Coltey2, Y. Lemeille2, S. Dominique3, G. Gargala3, P. Domblides4, I. Accoceberry4, G. Loeuille5, I. Durand-Joly5, A. Fanton6, O. Vagnier6, F. Dalle6, A. Boldron5, C. Llerena2, C. Pinel2, J.L. Ginies7, M. Pihet7, C. Person7, J. Bouchara7, N. Wizla1, C. Marguet3, L. Favenne3, S. Bui4, L. Delhaes1. 1CHRU, Lille, France; 2CHU, Grenoble, France; 3CHU, Rouen, France; 4CHU, Bordeaux, France; 5CHG, Dunkerque, France; 6CHU, Dijon, France; 7CHU, Angers, France
Journals
2009 EN
F. Vasseur · C. Gower-Rousseau · G. VernierMassouille
+9 more
RESULTS: At diagnosis, 25 children (9.5 % ) showed height < ! 2 s.d., 70 (27 % ) weight < ! 2 s.d., and 84 (32 % ) BMI < ! 2 s.d. At maximal follow-up, growth retardation was present in 18 children (6.9 % ) whereas 40 (15 % ) had malnutrition. Nutritional status was more severely impaired in children with stricturing disease. Growth and nutritional retardation at diagnosis, young age, male gender, and extraintestinal manifestations at diagnosis were indicators of poor prognosis. A signifi cant compen- sation was observed for weight and BMI in both genders and for height in girls. No treatment was associated with height, weight, or BMI at maximal follow-up. CONCLUSIONS: In a pediatric population-based study, growth retardation and severe malnutrition are still present at maximal follow-up in 6.9 and 15 % of CD children, respectively. Young boys with substantial infl am- matory manifestations of CD have a higher risk of subsequent growth failure, especially when growth retardation is present at diagnosis.